58160-976Level 3
Bexsero (NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN)
**Product type:** Vaccine
**Active ingredient:** NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN
**Strength:** 50; 50; 50; 25 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
**Dosage form:** Injection, Suspension
**Route:** Intramuscular
**Labeler:** GlaxoSmithKline Biologicals SA
**Marketing category:** BLA (BLA125546)
GET
/api/v1/systems/ndc_fda/nodes/58160-976Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.